Citation: | LI Guojun, ZHAO Kai, YAO Yuyuan, SHEN Le, GUO Qinglong. Effects and mechanism of programmed cell death of human gastric cancer cell under the treatment of flavonoid compound GL-V9[J]. Journal of China Pharmaceutical University, 2015, 46(4): 464-468. DOI: 10.11665/j.issn.1000-5048.20150413 |
[1] |
Shi J,Qu YP,Hou P,et al.Pathogenetic mechanisms in gastric cancer[J].World J Gastroenterol,2014,20(38):13804-13819.
|
[2] |
ShumH,Rajdev L.Multimodality management of resectable gastric cancer:a review[J].World J Gastrointestinal Oncol,2014,6(10):393.
|
[3] |
Li L, Lu N, Dai Q, et al. GL-V9,a newly synthetic flavonoid derivative,induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells[J].Eur J Pharmacol,2011,670(1):13-21.
|
[4] |
Li L, Chen P, Ling Y, et al. Inhibitory effects of GL-V9 on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-2/9[J].Eur J Pharm Sci,2011,43(5):393-399.
|
[5] |
Pasechnikov V,Chukov S,Fedorov E,et al.Gastric cancer:prevention,screening and early diagnosis[J].World J Gastroenterol,2014,20(38):13842.
|
[6] |
Baumann S,Fas SC,Giaisi M,et al.Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCγ1-and Ca2+-dependent apoptosis[J].Blood,2008,111(4):2354-2363.
|
[7] |
Fuchs Y,Steller H.Programmed cell death in animal development and disease[J].Cell,2011,147(4):742-758.
|
[8] |
Yuan J,Kroemer G.Alternative cell death mechanisms in development and beyond[J].Genes Dev,2010,24(23):2592-2602.
|
[9] |
Pinton P,Giorgi C,Siviero R,et al.Calcium and apoptosis:ER-mitochondria Ca2+ transfer in the control of apoptosis[J].Oncogene,2008,27(50):6407-6418.
|
[10] |
Clapham DE.Calcium signaling[J].Cell,2007,131(6):1047-1058.
|